We are live on
!
Find out more
Eli Lilly
2,443 hedge funds and large institutions have $255B invested in Eli Lilly in 2022 Q2 according to their latest regulatory filings, with 211 funds opening new positions, 867 increasing their positions, 915 reducing their positions, and 81 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4% more call options, than puts
Call options by funds: $1.87B | Put options by funds: $1.79B
0.09% more ownership
Funds ownership: 82.83% → 82.92% (+0.09%)
5% less repeat investments, than reductions
Existing positions increased: 867 | Existing positions reduced: 915
Holders
2,443
Holding in Top 10
183
Calls
$1.87B
Puts
$1.79B
Top Buyers
| 1 | +$1.92B | |
| 2 | +$1.06B | |
| 3 | +$875M | |
| 4 |
Jennison Associates
New York
|
+$737M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$340M |
Top Sellers
| 1 | -$1.16B | |
| 2 | -$1.14B | |
| 3 | -$598M | |
| 4 |
Fisher Asset Management
Camas,
Washington
|
-$471M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$442M |